Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains - PubMed (original) (raw)
. 2015 Apr;133(2):199-210.
doi: 10.1111/jnc.13047. Epub 2015 Feb 26.
Affiliations
- PMID: 25626691
- DOI: 10.1111/jnc.13047
Free article
Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains
Ole V Mortensen et al. J Neurochem. 2015 Apr.
Free article
Abstract
Excitatory amino acid transporters (EAATs) regulate glutamatergic signal transmission by clearing extracellular glutamate. Dysfunction of these transporters has been implicated in the pathogenesis of various neurological disorders. Previous studies have shown that venom from the spider Parawixia bistriata and a purified compound (Parawixin1) stimulate EAAT2 activity and protect retinal tissue from ischemic damage. In the present study, the EAAT2 subtype specificity of this compound was explored, employing chimeric proteins between EAAT2 and EAAT3 transporter subtypes and mutants to characterize the structural region targeted by the compound. This identified a critical residue (Histidine-71 in EAAT2 and Serine-45 in EAAT3) in transmembrane domain 2 (TM2) to be important for the selectivity between EAAT2 and EAAT3 and for the activity of the venom. Using the identified residue in TM2 as a structural anchor, several neighboring amino acids within TM5 and TM8 were identified to also be important for the activity of the venom. This structural domain of the transporter lies at the interface of the rigid trimerization domain and the central substrate-binding transport domain. Our studies suggest that the mechanism of glutamate transport enhancement involves an interaction with the transporter that facilitates the movement of the transport domain. We identified a domain (purple star) in the glutamate transporter EAAT2 that is important for transport stimulation through a spider venom, and suggest a mechanism for enhanced transporter function through facilitated substrate translocation (arrow). Because the dysfunction of glutamate transporters is implicated in the pathogenesis of neurological disorders, understanding the mechanisms of enhanced transport could have therapeutic implications.
Keywords: Parawixia bistriata; excitatory amino acid transporter 2 (EAAT2); glutamate transporter; glutamate uptake; transport enhancement.
© 2015 International Society for Neurochemistry.
Similar articles
- Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom.
Fontana AC, de Oliveira Beleboni R, Wojewodzic MW, Ferreira Dos Santos W, Coutinho-Netto J, Grutle NJ, Watts SD, Danbolt NC, Amara SG. Fontana AC, et al. Mol Pharmacol. 2007 Nov;72(5):1228-37. doi: 10.1124/mol.107.037127. Epub 2007 Jul 23. Mol Pharmacol. 2007. PMID: 17646426 - Parawixin1: a spider toxin opening new avenues for glutamate transporter pharmacology.
Torres-Salazar D, Fahlke C. Torres-Salazar D, et al. Mol Pharmacol. 2007 Nov;72(5):1100-2. doi: 10.1124/mol.107.041020. Epub 2007 Aug 28. Mol Pharmacol. 2007. PMID: 17726155 - Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2.
Kortagere S, Mortensen OV, Xia J, Lester W, Fang Y, Srikanth Y, Salvino JM, Fontana ACK. Kortagere S, et al. ACS Chem Neurosci. 2018 Mar 21;9(3):522-534. doi: 10.1021/acschemneuro.7b00308. Epub 2017 Nov 30. ACS Chem Neurosci. 2018. PMID: 29140675 - Current approaches to enhance glutamate transporter function and expression.
Fontana AC. Fontana AC. J Neurochem. 2015 Sep;134(6):982-1007. doi: 10.1111/jnc.13200. Epub 2015 Aug 14. J Neurochem. 2015. PMID: 26096891 Review. - The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.
Alijanpour S, Miryounesi M, Ghafouri-Fard S. Alijanpour S, et al. Metab Brain Dis. 2023 Jan;38(1):1-16. doi: 10.1007/s11011-022-01091-5. Epub 2022 Sep 29. Metab Brain Dis. 2023. PMID: 36173507 Review.
Cited by
- Synthesis and Structure-Activity Relationships for Glutamate Transporter Allosteric Modulators.
Fontana ACK, Poli ANR, Gour J, Srikanth YVV, Anastasi N, Ashok D, Khatiwada A, Reeb KL, Cheng MH, Bahar I, Rawls SM, Salvino JM. Fontana ACK, et al. J Med Chem. 2024 Apr 25;67(8):6119-6143. doi: 10.1021/acs.jmedchem.3c01909. Epub 2024 Apr 16. J Med Chem. 2024. PMID: 38626917 Free PMC article. - The Influence of the Substrate on the Functionality of Spin Crossover Molecular Materials.
Yazdani S, Phillips J, Ekanayaka TK, Cheng R, Dowben PA. Yazdani S, et al. Molecules. 2023 Apr 26;28(9):3735. doi: 10.3390/molecules28093735. Molecules. 2023. PMID: 37175145 Free PMC article. Review. - A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases.
Fontana IC, Souza DG, Souza DO, Gee A, Zimmer ER, Bongarzone S. Fontana IC, et al. J Med Chem. 2023 Feb 23;66(4):2330-2346. doi: 10.1021/acs.jmedchem.2c01572. Epub 2023 Feb 14. J Med Chem. 2023. PMID: 36787643 Free PMC article. Review. - Discovery of (R)-_N_-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.
Abram M, Jakubiec M, Reeb K, Cheng MH, Gedschold R, Rapacz A, Mogilski S, Socała K, Nieoczym D, Szafarz M, Latacz G, Szulczyk B, Kalinowska-Tłuścik J, Gawel K, Esguerra CV, Wyska E, Müller CE, Bahar I, Fontana ACK, Wlaź P, Kamiński RM, Kamiński K. Abram M, et al. J Med Chem. 2022 Sep 8;65(17):11703-11725. doi: 10.1021/acs.jmedchem.2c00534. Epub 2022 Aug 19. J Med Chem. 2022. PMID: 35984707 Free PMC article. - Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.
Green JL, Dos Santos WF, Fontana ACK. Green JL, et al. Biochem Pharmacol. 2021 Nov;193:114786. doi: 10.1016/j.bcp.2021.114786. Epub 2021 Sep 24. Biochem Pharmacol. 2021. PMID: 34571003 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources